BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 15, 2010
 |  BC Week In Review  |  Company News  |  Deals

Bioniche, Endo deal

Endo exercised an option to license exclusive, worldwide rights to Urocidin from Bioniche. Endo gained the option last year, when it licensed U.S. rights to the mycobacterial cell wall-DNA...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >